Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05047_nanopub.RARccdGkglYowhWDUhIhq10_WLrjB7kSREF7O3l3FZIjc#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB05047 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05047 label "CX717 [drugbank:DB05047]" assertion.
- drugbank:DB05047 seeAlso DB05047 assertion.
- drugbank:DB05047 identifier "drugbank:DB05047" assertion.
- drugbank:DB05047 description "CX717 is an ampakine compound created by Dr. Gary Lynch at UCI in 1993 and further developed by Cortex Pharmaceuticals, an Irvine company created to explore possible applications. It is one of a class of synthetic compounds that amplify the signal of glutamate, a neurotransmitter important for learning and memory." assertion.
- drugbank:DB05047 title "CX717" assertion.
- drugbank:DB05047 bio2rdf_vocabulary:identifier "DB05047" assertion.
- drugbank:DB05047 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05047 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05047" assertion.
- drugbank:DB05047 bio2rdf_vocabulary:x-identifiers.org DB05047 assertion.
- drugbank:DB05047 drugbank_vocabulary:drugbank-id "DB05047" assertion.
- drugbank:DB05047 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05047 drugbank_vocabulary:x-wikipedia wikipedia:CX717 assertion.